Big Gainers: Would You Buy PIXY, AMLX, ASAN, FHS, BVXV, BASE, NEXI Today?

After two days of straight losses, the market has finally seemed to move up today. This morning we see several new stocks that are surging purely on the positive news. Will you be interested in purchasing the best one out of seven big movers?

Just yesterday Asana reported income loss and topped revenue estimates. Today some buyers do really wish to have ASAN shares which are rising by 24%.

Out of nowhere, Shiftpixy pops out with good news to shareholders and PIXY is rocketing 125% today.

FDA decides to have a meeting regarding Amylyx’s controversial ALS drug then AMLX soars 76% in an hour.

First High-School Education has released its unaudited first half of 2022 financial report. Due to some promising financial standings inside the report FHS shares are gaining 23%.

Along with Selexis, Neximune is signing a service contract to develop therapies against rare cancers and autoimmune disorders. NEXI is firmly growing by 18% today.

Via Motley Fool Couchbase shared the Q2 2023 earnings call transcript. Eventually, its BASE shares are rising by 17%.

Merchandising and brand marketing services provider SPAR Group inform stakeholders to review strategic alternatives to push the company to the next level. Later in an hour, SGPR started surging by 10%.